Haqq Christopher bought ELTX
July 16, 2026 · Form 4 insider transaction
Haqq Christopher bought 64,643 shares of Elicio Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
64,643
Price
$0.00
Total value
N/A
InsiderHaqq Christopher
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJuly 16, 2026
Filing dateJuly 17, 2026
Shares owned after64,643
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option vests and becomes exercisable as to 50% of the options on July 16, 2027, the first anniversary of the grant date, and as to the remaining 50% of the options on July 16, 2028, the second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.